Trigeminal Nerve Stimulation of the Treatment of Epilepsy

NAActive, not recruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 8, 2025

Primary Completion Date

May 8, 2026

Study Completion Date

June 30, 2026

Conditions
Epilepsy (Treatment Refractory)
Interventions
DEVICE

Trigeminal nerve stimulation

"The study device, Cefaly® Connected, is a non-invasive neuromodulation tool designed for the prevention and treatment of migraine headaches. It works by delivering transcutaneous electrical stimulation to the bilateral supraorbital nerves, which are branches of the trigeminal nerve. The device is placed on the forehead, and it emits electrical impulses that modulate the activity of the trigeminal nerve."

Trial Locations (1)

77080

Debakey VA Medical Center, Houston

All Listed Sponsors
collaborator

Michael E. DeBakey VA Medical Center

FED

lead

Baylor College of Medicine

OTHER

NCT07220161 - Trigeminal Nerve Stimulation of the Treatment of Epilepsy | Biotech Hunter | Biotech Hunter